Lumiradx Limited Warrant Stock EBITDA
LumiraDx Limited Warrant fundamentals help investors to digest information that contributes to LumiraDx Limited's financial success or failures. It also enables traders to predict the movement of LumiraDx Stock. The fundamental analysis module provides a way to measure LumiraDx Limited's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LumiraDx Limited stock.
LumiraDx |
LumiraDx Limited Warrant Company EBITDA Analysis
LumiraDx Limited's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current LumiraDx Limited EBITDA | (273.54 M) |
Most of LumiraDx Limited's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LumiraDx Limited Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, LumiraDx Limited Warrant reported earnings before interest,tax, depreciation and amortization of (273.54 Million). This is 131.18% lower than that of the Biotechnology sector and 178.85% lower than that of the Health Care industry. The ebitda for all United States stocks is 107.02% higher than that of the company.
LumiraDx EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LumiraDx Limited's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LumiraDx Limited could also be used in its relative valuation, which is a method of valuing LumiraDx Limited by comparing valuation metrics of similar companies.LumiraDx Limited is currently under evaluation in ebitda category among its peers.
LumiraDx Fundamentals
| Return On Asset | -0.28 | |||
| Profit Margin | (2.67) % | |||
| Operating Margin | (2.31) % | |||
| Number Of Shares Shorted | 101.28 K | |||
| Revenue | 254.48 M | |||
| EBITDA | (273.54 M) | |||
| Net Income | (449.19 M) | |||
| Total Debt | 401.25 M | |||
| Book Value Per Share | (4.56) X | |||
| Cash Flow From Operations | (162.11 M) | |||
| Earnings Per Share | (2.93) X | |||
| Number Of Employees | 1.21 K | |||
| Beta | 1.71 | |||
| Total Asset | 441.01 M | |||
| Retained Earnings | (1.09 B) | |||
| Working Capital | 179.82 M | |||
| Z Score | -4.44 | |||
| Net Asset | 441.01 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx Limited Warrant check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx Limited's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |